[HTML][HTML] Lack of basophil CD203c upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic …
T Palacios, L Stillman, L Borish… - The journal of allergy and …, 2016 - ncbi.nlm.nih.gov
Chronic urticaria (CU) is defined as recurrent, transitory, pruritic-raised wheals present on
most days of the week for> 6 weeks1. The pathogenesis of CU is unknown; but it is thought …
most days of the week for> 6 weeks1. The pathogenesis of CU is unknown; but it is thought …
Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic …
T Palacios, L Stillman, L Borish… - The Journal of Allergy …, 2015 - europepmc.org
Chronic urticaria (CU) is defined as recurrent, transitory, pruritic-raised wheals present on
most days of the week for> 6 weeks 1. The pathogenesis of CU is unknown; but it is thought …
most days of the week for> 6 weeks 1. The pathogenesis of CU is unknown; but it is thought …
[引用][C] Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic …
T Palacios, L Stillman, L Borish… - The Journal of Allergy …, 2016 - jaci-inpractice.org
Chronic urticaria (CU) is defined as recurrent, transitory, pruritic-raised wheals present on
most days of the week for more than 6 weeks. 1 The pathogenesis of CU is unknown, but it is …
most days of the week for more than 6 weeks. 1 The pathogenesis of CU is unknown, but it is …
[引用][C] Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic …
T Palacios, L Stillman, L Borish… - The Journal of Allergy and …, 2016 - cir.nii.ac.jp
Lack of basophil CD203c-upregulating activity as an immunological marker to predict response
to treatment with omalizumab in patients with symptomatic chronic urticaria | CiNii Research …
to treatment with omalizumab in patients with symptomatic chronic urticaria | CiNii Research …
[引用][C] Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic …
T Palacios, L Stillman, L Borish… - The journal of allergy …, 2016 - pubmed.ncbi.nlm.nih.gov
Lack of basophil CD203c-upregulating activity as an immunological marker to predict response
to treatment with omalizumab in patients with symptomatic chronic urticaria Lack of basophil …
to treatment with omalizumab in patients with symptomatic chronic urticaria Lack of basophil …
Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic …
T Palacios, L Stillman, L Borish… - The Journal of Allergy …, 2015 - europepmc.org
Chronic urticaria (CU) is defined as recurrent, transitory, pruritic-raised wheals present on
most days of the week for> 6 weeks1. The pathogenesis of CU is unknown; but it is thought …
most days of the week for> 6 weeks1. The pathogenesis of CU is unknown; but it is thought …